Upregulated p53 expression activates apoptotic pathways in wild-type p53-bearing mesothelioma and enhances cytotoxicity of cisplatin and pemetrexed.

Upregulated p53 expression activates apoptotic pathways in wild-type p53-bearing mesothelioma and enhances cytotoxicity of cisplatin and pemetrexed.

Item
http://www.wikidata.org/entity/Q53193985
Oncolytic virotherapy for human malignant mesothelioma: recent advancesZoledronic acid produces combinatory anti-tumor effects with cisplatin on mesothelioma by increasing p53 expression levels.Interferon-β produces synergistic combinatory anti-tumor effects with cisplatin or pemetrexed on mesothelioma cells.Cytotoxic effects of replication-competent adenoviruses on human esophageal carcinoma are enhanced by forced p53 expression.Metformin produces growth inhibitory effects in combination with nutlin-3a on malignant mesothelioma through a cross-talk between mTOR and p53 pathways.Inauhzin sensitizes p53-dependent cytotoxicity and tumor suppression of chemotherapeutic agents.Gene therapy for malignant mesothelioma: current prospects and challenges.Co-targeting of FAK and MDM2 triggers additive anti-proliferative effects in mesothelioma via a coordinated reactivation of p53.Expression of p53 synergistically augments caspases-mediated apoptosis induced by replication-competent adenoviruses in pancreatic carcinoma cells.NEDD4 is involved in acquisition of epithelial-mesenchymal transition in cisplatin-resistant nasopharyngeal carcinoma cells.Efficient one-pot synthesis of trans-Pt(II)(salicylaldimine)(4-picoline)Cl complexes: effective agents for enhanced expression of p53 tumor suppressor genes.A potential therapeutic strategy for malignant mesothelioma with gene medicine.Heat shock protein 90 inhibitors augment endogenous wild-type p53 expression but down-regulate the adenovirally-induced expression by inhibiting a proteasome activity.
P2860

Upregulated p53 expression activates apoptotic pathways in wild-type p53-bearing mesothelioma and enhances cytotoxicity of cisplatin and pemetrexed.

Item
http://www.wikidata.org/entity/Q53193985
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Upregulated p53 expression act ...... y of cisplatin and pemetrexed.
@en
Upregulated p53 expression act ...... y of cisplatin and pemetrexed.
@nl
type
label
Upregulated p53 expression act ...... y of cisplatin and pemetrexed.
@en
Upregulated p53 expression act ...... y of cisplatin and pemetrexed.
@nl
prefLabel
Upregulated p53 expression act ...... y of cisplatin and pemetrexed.
@en
Upregulated p53 expression act ...... y of cisplatin and pemetrexed.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
Upregulated p53 expression act ...... y of cisplatin and pemetrexed.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P698
P921